Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 264

1.
2.

Comparative effectiveness of renin-angiotensin system blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis.

Wu HY, Huang JW, Lin HJ, Liao WC, Peng YS, Hung KY, Wu KD, Tu YK, Chien KL.

BMJ. 2013 Oct 24;347:f6008. doi: 10.1136/bmj.f6008. Review.

3.

A meta-analysis reporting effects of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers in patients without heart failure.

Savarese G, Costanzo P, Cleland JG, Vassallo E, Ruggiero D, Rosano G, Perrone-Filardi P.

J Am Coll Cardiol. 2013 Jan 15;61(2):131-42. doi: 10.1016/j.jacc.2012.10.011. Epub 2012 Dec 5.

4.

Angiotensin converting enzyme (ACE) inhibitors versus angiotensin receptor blockers for primary hypertension.

Li EC, Heran BS, Wright JM.

Cochrane Database Syst Rev. 2014 Aug 22;8:CD009096. doi: 10.1002/14651858.CD009096.pub2. Review.

PMID:
25148386
5.

Effect of angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on risk of atrial fibrillation before coronary artery bypass grafting.

Johnston K, Stephens S.

Ann Pharmacother. 2012 Sep;46(9):1239-44. doi: 10.1345/aph.1R128. Epub 2012 Sep 4. Review.

PMID:
22947592
6.
7.

Meta-analysis: angiotensin-receptor blockers in chronic heart failure and high-risk acute myocardial infarction.

Lee VC, Rhew DC, Dylan M, Badamgarav E, Braunstein GD, Weingarten SR.

Ann Intern Med. 2004 Nov 2;141(9):693-704. Erratum in: Ann Intern Med. 2005 Mar 1;42(5):391. Dosage error in article text.

PMID:
15520426
8.

Tolerability of angiotensin-receptor blockers in patients with intolerance to angiotensin-converting enzyme inhibitors: a systematic review and meta-analysis.

Caldeira D, David C, Sampaio C.

Am J Cardiovasc Drugs. 2012 Aug 1;12(4):263-77. doi: 10.2165/11599990-000000000-00000. Review.

PMID:
22587776
9.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers for treating essential hypertension.

Matchar DB, McCrory DC, Orlando LA, Patel MR, Patel UD, Patwardhan MB, Powers B, Samsa GP, Gray RN.

Ann Intern Med. 2008 Jan 1;148(1):16-29. Epub 2007 Nov 5. Review.

PMID:
17984484
10.

Angiotensin receptor blockers for heart failure.

Heran BS, Musini VM, Bassett K, Taylor RS, Wright JM.

Cochrane Database Syst Rev. 2012 Apr 18;4:CD003040. doi: 10.1002/14651858.CD003040.pub2. Review.

PMID:
22513909
11.

Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers for adults with early (stage 1 to 3) non-diabetic chronic kidney disease.

Sharma P, Blackburn RC, Parke CL, McCullough K, Marks A, Black C.

Cochrane Database Syst Rev. 2011 Oct 5;(10):CD007751. doi: 10.1002/14651858.CD007751.pub2. Review.

PMID:
21975774
12.

Meta-analysis: effect of monotherapy and combination therapy with inhibitors of the renin angiotensin system on proteinuria in renal disease.

Kunz R, Friedrich C, Wolbers M, Mann JF.

Ann Intern Med. 2008 Jan 1;148(1):30-48. Epub 2007 Nov 5.

PMID:
17984482
13.

Pneumonia risk and use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers.

Liu CL, Shau WY, Chang CH, Wu CS, Lai MS.

J Epidemiol. 2013 Sep 5;23(5):344-50. Epub 2013 Aug 3.

15.

Systematic review: comparative effectiveness of angiotensin-converting enzyme inhibitors or angiotensin II-receptor blockers for ischemic heart disease.

Baker WL, Coleman CI, Kluger J, Reinhart KM, Talati R, Quercia R, Phung OJ, White CM.

Ann Intern Med. 2009 Dec 15;151(12):861-71. doi: 10.7326/0003-4819-151-12-200912150-00162. Review.

PMID:
20008762
16.

A systematic review of the pharmacological management of aortic root dilation in Marfan syndrome.

Thakur V, Rankin KN, Hartling L, Mackie AS.

Cardiol Young. 2013 Aug;23(4):568-81. doi: 10.1017/S1047951112001412. Epub 2012 Oct 19. Review.

PMID:
23083542
17.

Cardiovascular outcomes in high-risk patients without heart failure treated with ARBs: a systematic review and meta-analysis.

Al Khalaf MM, Thalib L, Doi SA.

Am J Cardiovasc Drugs. 2009;9(1):29-43. doi: 10.2165/00129784-200909010-00004. Review.

PMID:
19178130
18.
20.

Angiotensin-converting enzyme inhibitors versus angiotensin receptor blockers for diabetic nephropathy: a retrospective comparison.

Robles NR, Romero B, Fernandez-Carbonero E, Sánchez-Casado E, Cubero JJ.

J Renin Angiotensin Aldosterone Syst. 2009 Dec;10(4):195-200. doi: 10.1177/1470320309352352.

PMID:
20026868
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk